PMID: 9170483Jun 1, 1997Paper

Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study

Obstetrics and Gynecology
R E HemplingC J Mettlin

Abstract

To evaluate the role of hormone replacement therapy (HRT) as a risk factor for the development of epithelial ovarian cancer. A case-control study was performed that used 491 patients with epithelial ovarian cancer frequency matched for age at diagnosis (+/-5 years) with a control population of 741 patients with malignancies of nonestrogen-dependent tissues. The odds ratio (OR) for the development of epithelial ovarian cancer was estimated using logistic regression analysis with adjustment for age at diagnosis, parity, oral contraceptive use, smoking history, family history of epithelial ovarian cancer, age at menarche, menopausal status, income, and education. One hundred of 491 patients (20.4%) in the study population had ever used HRT, and 160 of 741 patients (21.6%) in the control population had ever used HRT (OR 0.85; 95% confidence interval [CI] 0.62, 1.2). A significant association between HRT and specific histologic subtypes of epithelial ovarian cancer was not demonstrable for serous cystadenocarcinoma (OR 1.2, 95% CI 0.8, 1.7), Clear cell carcinoma (OR 1.1, 95% CI 0.4, 3.4), or endometrioid carcinoma (OR 0.4; 95% CI 0.2, 1.2). A significant association between duration of use of HRT and the risk of developing epithelia...Continue Reading

References

Dec 4, 1975·The New England Journal of Medicine·H K Ziel, W D Finkle
Apr 1, 1992·British Journal of Obstetrics and Gynaecology·P J RyanI Fogelman
Jan 1, 1989·American Journal of Obstetrics and Gynecology·N N BhatiaM M Karram
May 1, 1987·American Journal of Obstetrics and Gynecology·V A Ravnikar
Jul 1, 1986·Maturitas·R D Gambrell
Oct 1, 1985·The Journal of Clinical Endocrinology and Metabolism·K A SteingoldH L Judd
Jun 15, 1995·The New England Journal of Medicine·G A ColditzF E Speizer
Sep 30, 1993·International Journal of Cancer. Journal International Du Cancer·A PolychronopoulouD Trichopoulos
Oct 14, 1993·The New England Journal of Medicine·D T FelsonJ J Anderson
Feb 1, 1996·Obstetrics and Gynecology·R A Wild
Feb 1, 1996·Obstetrics and Gynecology·J M Sullivan, L P Fowlkes

❮ Previous
Next ❯

Citations

Aug 15, 2000·Journal of Cellular Physiology·D ZhangK J Soprano
Apr 26, 2001·Journal of Surgical Oncology·G H EltabbakhC J Mettlin
Feb 12, 2008·Cancer Causes & Control : CCC·Karen J WernliKathleen M Egan
Jul 16, 2009·Current Treatment Options in Oncology·Thanasak Sueblinvong, Michael E Carney
Sep 12, 2001·The Surgical Clinics of North America·K Lin, C D Runowicz
Aug 22, 2001·Maturitas·C La VecchiaA McTiernan
Nov 22, 2001·Maturitas·A R GenazzaniUNKNOWN International Menopause Society Expert Workshop
Apr 17, 2002·Maturitas·Adolf E Schindler
Mar 18, 1999·Hematology/oncology Clinics of North America·G Emons, J J Kavanagh
Apr 29, 2000·Journal of Clinical Epidemiology·S S CoughlinN C Lee
Mar 3, 1998·Journal of the American College of Surgeons·E L Yordan
Sep 2, 1999·Journal of the National Cancer Institute·R B Ness, C Cottreau
Sep 14, 2001·Current Opinion in Oncology·V Mahavni, A K Sood
Mar 4, 1998·Current Opinion in Obstetrics & Gynecology·C W Burger, P Kenemans
May 11, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·V LoizziL Selvaggi
Sep 27, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y F LiJ J Kavanagh
Aug 19, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Tomas RimanIngemar R Persson
Mar 18, 2005·The Journal of Obstetrics and Gynaecology Research·Leon Speroff
May 5, 2001·Expert Opinion on Pharmacotherapy·G H Eltabbakh, C S Awtrey
Dec 26, 2009·Journal of Ovarian Research·Subhash C ChauhanMeena Jaggi
Oct 9, 2001·Nutrition and Cancer·S E McCannC Mettlin
Jul 21, 2004·Gynecologic Oncology·Séverine CunatPascal Pujol
Feb 24, 2005·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·A GadducciA R Genazzani
Apr 27, 2017·American Journal of Epidemiology·Lauren C PeresJoellen M Schildkraut
Oct 3, 1999·British Journal of Cancer·D M PurdieA C Green
Jun 6, 2002·Acta Obstetricia Et Gynecologica Scandinavica·Aila Tiitinen
Jun 19, 2007·Human Reproduction Update·Claudia M GreiserMartina Dören
Mar 26, 2004·The Linacre Quarterly·Elio Sgreccia, Maria Luisa Di Pietro
Oct 28, 2015·Menopause : the Journal of the North American Menopause Society·Li-feng ShiCai-yun Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.